NCT07543172 2026-04-21
CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer
Roswell Park Cancer Institute
Phase 2 Not yet recruiting
Clinical Trials
12 trialsNCT06249282 2026-04-03
Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer
City of Hope Medical Center
Phase 1 Recruiting
NCT06582771 2026-03-25
A Study of Sotorasib in People With Non-Small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT05845450 2026-03-12
Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)
Gruppo Oncologico del Nord-Ovest
Phase 2 Recruiting
NCT07318389 2026-02-27
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT06333678 2026-01-29
A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC)
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT05815173 2025-12-30
Ladarixin With Sotorasib in Advanced NSCLC
NYU Langone Health
Phase 1 Recruiting
NCT05313009 2025-12-16
Tarlox and Sotorasib in Patients With KRAS G12C Mutations
Medical University of South Carolina
Phase 1/2 Terminated
NCT05118854 2025-10-20
A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT07124884 2025-08-15
COLOSOTO
Federation Francophone de Cancerologie Digestive
Phase 2 Not yet recruiting
NCT06807619 2025-05-22
A Study of Sotorasib in People With Brain Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT05631249 2025-05-08
CODEBREAK-IGR
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Recruiting